3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Active not recruiting
2
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
2
Other hematologic neoplasm
1
Myeloid
1
Conditions
Breast Neoplasms
2
Interventions
pembrolizumab
78
Fulvestrant
76
Carboplatin
74
Trastuzumab
71
Capecitabine
69
Letrozole
62
Cyclophosphamide
61
Paclitaxel
60
pertuzumab
52
Specimen Handling
52
Docetaxel
50
abemaciclib
46
ribociclib
44
Anastrozole
35
130-nm albumin-bound paclitaxel
35
trastuzumab deruxtecan
34
Magnetic Resonance Spectroscopy
33
Blood Specimen Collection
33
Tamoxifen
32
sacituzumab govitecan
31
exemestane
31
Biopsy
31
Gemcitabine
30
Epirubicin
29
pyrotinib
28
palbociclib
28
Surveys and Questionnaires
27
Injections
27
Drug Therapy
27
eribulin
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Genetic Profile
×
Breast
×
Clear all
NCT05652569
2026-01-28
CATCH
German Cancer Research Center
Recruiting
5,000 enrolled
NCT05906407
2025-03-19
COGNITION
German Cancer Research Center
Recruiting
2,000 enrolled